Source: 4-TRADERS

BioAlliance Pharma: ONXEO : Belinostat abstracts for American Association for Cancer Research 2015 - Abstracts om belinostat p� 2014 �rsm�det i American Association for Cancer Research

(4-traders.com) 20 Apr, 2015 Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announced that preclinical and clinical data on belinostat will be presented at the 2015 American Association for Cancer Research (AACR) Annual Meeting (April 18-22, 2015)...http://www.4-traders.com/ONXEO-17068163/news/ONXEO--Belinostat-abstracts-for-American-Association-for-Cancer-Research-2015-ndash-Abstracts-om-20223591/

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



BioAlliance Pharma is a Private company. BioAlliance Pharma has a revenue of $10M, and 10 employees. BioAlliance Pharma has 1 followers on Owler.